MDMX (MDM4) Mouse Monoclonal Antibody [Clone ID: OTI4B5]
CAT#: TA505706
MDM4 (MDMX) mouse monoclonal antibody, clone OTI4B5 (formerly 4B5)
Size: 30 ul
Formulation: Carrier-Free
View other "OTI4B5" antibodies (4)
Need it in bulk or conjugated?
Get a free quote
CNY 1,999.00
CNY 2,700.00
Cited in 8 publications. |
CNY 3,080.00
CNY 300.00
CNY 1,430.00
Specifications
Product Data | |
Clone Name | OTI4B5 |
Applications | IF, IHC, WB |
Recommend Dilution | WB 1:200~2000, IHC 1:150, IF 1:100 |
Reactivity | Human |
Host | Mouse |
Clonality | Monoclonal |
Immunogen | Full length human recombinant protein of human MDM4(NP_002384) produced in HEK293T cell. |
Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. |
Concentration | 1 mg/ml |
Purification | Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G) |
Conjugation | Unconjugated |
Storage Condition | Store at -20°C as received. |
Predicted Protein Size | 54.7 kDa |
Gene Name | MDM4 regulator of p53 |
Database Link | |
Background | This gene encodes a nuclear protein that contains a p53 binding domain at the N-terminus and a RING finger domain at the C-terminus, and shows structural similarity to p53-binding protein MDM2. Both proteins bind the p53 tumor suppressor protein and inhibit its activity, and have been shown to be overexpressed in a variety of human cancers. However, unlike MDM2 which degrades p53, this protein inhibits p53 by binding its transcriptional activation domain. This protein also interacts with MDM2 protein via the RING finger domain, and inhibits the latter's degradation. So this protein can reverse MDM2-targeted degradation of p53, while maintaining suppression of p53 transactivation and apoptotic functions. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Feb 2011] |
Synonyms | HDMX; MDMX; MRP1 |
Reference Data | |
Protein Families | Druggable Genome, Transcription Factors |
Protein Pathways | p53 signaling pathway |
Citations (8)
The use of this Antibodies has been cited in the following citations: |
---|
Inhibition of the mTOR pathway and reprogramming of protein synthesis by MDM4 reduce ovarian cancer metastatic properties
,Lucà, R;Assenza, MR;Maiullari, F;Pieroni, L;Maiullari, S;Federici, G;Marini, F;Rizzi, R;Urbani, A;Soddu, S;Moretti, F;,
Cell death & disease
,PubMed ID 34052831
[MDM4]
|
Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4
,Lucà, R;di Blasio, G;Gallo, D;Monteleone, V;Manni, I;Fici, L;Buttarelli, M;Ciolli, G;Pellegrino, M;Teveroni, E;Maiullari, S;Ciucci, A;Apollo, A;Mancini, F;Gentileschi, MP;Zannoni, GF;Pontecorvi, A;Scambia, G;Moretti, F;,
Cancers (Basel) 2019
,PubMed ID 31547268
[MDM4]
|
The Efflux Mechanism of Fraxetin-O-Glucuronides in UGT1A9-Transfected HeLa Cells: Identification of Multidrug Resistance-Associated Proteins 3 and 4 (MRP3/4) as the Important Contributors
,Qin, Z;Zhang, B;Yang, J;Li, S;Xu, J;Yao, Z;Zhang, X;Gonzalez, FJ;Yao, X;,
Front Pharmacol
,PubMed ID 31133859
[MDM4]
|
Sulfation disposition of liquiritigenin in SULT1A3 overexpressing HEK293 cells: The role of breast cancer resistance protein (BCRP) and multidrug resistance-associated protein 4 (MRP4) in sulfate efflux of liquiritigenin
,Liu, T;Zhang, X;Zhang, Y;Hou, J;Fang, D;Sun, H;Li, Q;Xie, S;,
Eur J Pharm Sci
,PubMed ID 30176366
[MDM4]
|
Efflux excretion of bisdemethoxycurcumin-O-glucuronide in UGT1A1-overexpressing HeLa cells: Identification of breast cancer resistance protein (BCRP) and multidrug resistance-associated proteins 1 (MRP1) as the glucuronide transporters
,Yang, J;Zhang, B;Qin, Z;Li, S;Xu, J;Yao, Z;Zhang, X;Gonzalez, FJ;Yao, X;,
Biofactors
,PubMed ID 30334318
[MDM4]
|
The roles of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated proteins (MRPs/ABCCs) in the excretion of cycloicaritin-3-O-glucoronide in UGT1A1-overexpressing HeLa cells
,Li, S;Xu, J;Yao, Z;Hu, L;Qin, Z;Gao, H;Krausz, KW;Gonzalez, FJ;Yao, X;,
Chem. Biol. Interact.
,PubMed ID 30237061
[MDM4]
|
MDM4 actively restrains cytoplasmic mTORC1 by sensing nutrient availability
,Mancini, F;Teveroni, E;Di Conza, G;Monteleone, V;Arisi, I;Pellegrino, M;Buttarelli, M;Pieroni, L;D'Onofrio, M;Urbani, A;Pontecorvi, A;Mazzone, M;Moretti, F;,
Mol. Cancer
,PubMed ID 28270148
[MDM4]
|
MDM4/HIPK2/p53 cytoplasmic assembly uncovers coordinated repression of molecules with anti-apoptotic activity during early DNA damage response
,Mancini, F;Pieroni, L;Monteleone, V;Lucà, R;Fici, L;Luca, E;Urbani, A;Xiong, S;Soddu, S;Masetti, R;Lozano, G;Pontecorvi, A;Moretti, F;,
Oncogene
,PubMed ID 25961923
[MDM4]
|
Documents
Product Manuals |
FAQs |
SDS |
Resources
抗体相关资料 |
Other Versions
SKU | Description | Size | Price |
---|---|---|---|
CF505706 | Carrier-free (BSA/glycerol-free) MDM4 mouse monoclonal antibody, clone OTI4B5 (formerly 4B5) |
CNY 3,999.00 |
|
TA505706AM | MDM4 mouse monoclonal antibody,clone 4B5, Biotinylated |
CNY 3,990.00 |
|
TA505706BM | MDM4 mouse monoclonal antibody,clone 4B5, HRP conjugated |
CNY 3,990.00 |
|
TA505706S | MDM4 (MDMX) mouse monoclonal antibody, clone OTI4B5 (formerly 4B5) |
CNY 800.00 |